Search
By Kathlyn Stone (journalist and former health
2 min read
What Is an Active Pharmaceutical Ingredient (API)?
The Active Pharmaceutical Ingredient (API) is the part of any drug that produces the intended effects. Some drugs, such as combination...
Kamini Anbil, The Confluence Elite Group, LLC.
4 min read
The Drug Naming Process
Drugs often have several names. A marketed drug may have up to four different types of names: a chemical name, a company name, a generic...
By Lizzie Crouch BBC Health Check
4 min read
The twists and turns of naming diseases
When a new disease is identified in a group of patients it needs a name so it can be described, researched and treated. But, unlike...
By Ram Subramanian
7 min read
Branding: When One is Not Enough
Launching a second brand is a marketing strategy to address an unmet need distinct from the current brand. In the pharmaceutical industry...
By Rachael Harper (European Pharmaceutical Review)
2 min read
Liposomal medicine names to be changed to avoid errors
The EMA has requested that liposomal medication names be changed to avoid the risk of confusion. All marketing authorisation holders of...
Michelle Ahern | senior consultant morganmckinley
2 min read
The difference between pharmaceutical and biotechnology
While sitting in a meeting recently I was asked, 'what exactly is the difference between pharma and biopharma?' For most of us, we may...
by Ed Silverman on DrugPatentWatch.com Posted with
3 min read
Biosimilar names may affect pharmacist dispensing habits
How biosimilars are named could influence the willingness of pharmacists to substitute such drugs for more expensive biologics, a survey...
By Jenny Staletovich | The Miami Herald
5 min read
Branders give products an identity
In the world of branding, there's a language all its own: Casodex, Grazax, Latisse, Symbicort and Vusion. Each one of those words is the...
by Eric Sagonowsky | Fiecepharma.com
2 min read
The top 10 drugs of 2024
EvaluatePharma analysts predict AbbVie's Humira will top pharma's sales charts in 2024, followed by Merck's Keytruda and Celgene's...
selected & edited by #pharmanaming.com
1 min read
FDA Draft Guidance Requiring Distinct Naming for Biosimilars
Biosimilar Naming Policy Will Help Ensure Patient Safety and Transparency ATLANTA – The American College of Rheumatology (ACR) today...